Finland· FI-REL-REL5158

Kinilentin

A quinidine product, registered in Finland by Schering Oy. The same ATC class is registered in 6 of our 19 countries.

ATC C01BA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedKinilentinATCC01BA01REGISTER NO.FI-REL-REL5158PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Quinidine is registered in 6 of 19 countries.

Countries holding a registration under ATC C01BA01 (quinidine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 3 of them publish a price we can compare per daily dose

Quinidine · ATC C01BA01

6 / 19 countries

  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Manufacturer
Schering Oy
Country
Finland (FI)
ATC code
C01BA01
ATC class
Quinidine
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

491 interactions on record for quinidine.

Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Quinidine · interactions on record

491 records

  • 135 severe
  • 198 moderate
  • 8 minor
  • 108 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

42 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b32cb3e7-afcf-49ba-8bfd-11ba53dec0d6
GET /v1/drugs/b32cb3e7-afcf-49ba-8bfd-11ba53dec0d6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1.2",
  "form": "depottabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "200 mg",
  "atc_label": "kinidiini",
  "ma_number": "6311",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL5158",
  "authorised_at": "1971-12-15"
}

See everything about quinidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.